For patients who face daily injections, the dream is simple: a needle-free way to receive their vital medications. The biggest obstacle to that dream is our own skin specifically its tough, outermost layer that brilliantly protects us but also locks out most medicines, severely limiting what can be effectively delivered through a patch. This is the challenge that a smart new technology called transferosomes is designed to solve. Think of them as ultra-adaptable, nano-scale delivery vehicles, engineered with a special blend of phospholipids and softening agents that give them a unique, stress-responsive squishiness. This allows them to deform and navigate through the skin's tightest natural pathways, reaching deep enough for systemic treatment. By examining the precise mechanobiology of how they work and refining how we make them, researchers are now pushing the boundaries to deliver high-molecular-weight biologics large, complex drugs like proteins and antibodies through the skin. The journey now is about navigating the complex path from laboratory success to pharmacy shelves, transforming this elegant science into accessible, bedside therapies that can fundamentally improve patient comfort and care.
Deekshitha2 Rakhesh R1* (Sun,) studied this question.